Fidelity Investments’s Agios Pharmaceuticals AGIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$618K Buy
18,592
+786
+4% +$26.1K ﹤0.01% 2888
2025
Q1
$522K Sell
17,806
-7,515
-30% -$220K ﹤0.01% 2885
2024
Q4
$832K Sell
25,321
-20,072
-44% -$660K ﹤0.01% 2734
2024
Q3
$2.02M Buy
45,393
+33,546
+283% +$1.49M ﹤0.01% 2398
2024
Q2
$511K Buy
11,847
+6,877
+138% +$297K ﹤0.01% 2724
2024
Q1
$145K Buy
4,970
+370
+8% +$10.8K ﹤0.01% 3139
2023
Q4
$102K Sell
4,600
-694
-13% -$15.5K ﹤0.01% 3204
2023
Q3
$131K Buy
5,294
+272
+5% +$6.73K ﹤0.01% 3012
2023
Q2
$142K Sell
5,022
-27
-0.5% -$765 ﹤0.01% 3045
2023
Q1
$116K Sell
5,049
-1,635,265
-100% -$37.6M ﹤0.01% 3158
2022
Q4
$46.1M Sell
1,640,314
-266,240
-14% -$7.48M ﹤0.01% 1285
2022
Q3
$53.9M Sell
1,906,554
-1,029,288
-35% -$29.1M 0.01% 1218
2022
Q2
$65.1M Sell
2,935,842
-1,882,650
-39% -$41.7M 0.01% 1138
2022
Q1
$140M Sell
4,818,492
-615,822
-11% -$17.9M 0.01% 932
2021
Q4
$179M Sell
5,434,314
-1,414,504
-21% -$46.5M 0.01% 850
2021
Q3
$316M Sell
6,848,818
-1,233,192
-15% -$56.9M 0.03% 612
2021
Q2
$445M Buy
8,082,010
+203,105
+3% +$11.2M 0.03% 478
2021
Q1
$407M Buy
7,878,905
+3,540,238
+82% +$183M 0.03% 503
2020
Q4
$188M Buy
4,338,667
+509,781
+13% +$22.1M 0.02% 769
2020
Q3
$134M Sell
3,828,886
-1,787,441
-32% -$62.6M 0.01% 793
2020
Q2
$300M Sell
5,616,327
-3,379,252
-38% -$181M 0.03% 459
2020
Q1
$319M Buy
8,995,579
+167,117
+2% +$5.93M 0.04% 362
2019
Q4
$422M Buy
8,828,462
+15,530
+0.2% +$742K 0.05% 377
2019
Q3
$286M Buy
8,812,932
+6,232
+0.1% +$202K 0.03% 492
2019
Q2
$439M Buy
8,806,700
+47,387
+0.5% +$2.36M 0.05% 361
2019
Q1
$591M Buy
8,759,313
+32,512
+0.4% +$2.19M 0.07% 271
2018
Q4
$402M Buy
8,726,801
+27,915
+0.3% +$1.29M 0.06% 347
2018
Q3
$671M Buy
8,698,886
+58,043
+0.7% +$4.48M 0.08% 249
2018
Q2
$728M Buy
8,640,843
+41,832
+0.5% +$3.52M 0.08% 224
2018
Q1
$703M Buy
8,599,011
+1,289,268
+18% +$105M 0.08% 256
2017
Q4
$418M Buy
7,309,743
+51,064
+0.7% +$2.92M 0.05% 406
2017
Q3
$485M Buy
7,258,679
+31,348
+0.4% +$2.09M 0.06% 337
2017
Q2
$372M Buy
7,227,331
+895,584
+14% +$46.1M 0.05% 423
2017
Q1
$370M Buy
6,331,747
+32,931
+0.5% +$1.92M 0.05% 426
2016
Q4
$263M Buy
6,298,816
+87,744
+1% +$3.66M 0.04% 553
2016
Q3
$328M Buy
6,211,072
+526,304
+9% +$27.8M 0.04% 465
2016
Q2
$238M Buy
5,684,768
+10,684
+0.2% +$448K 0.03% 591
2016
Q1
$230M Buy
5,674,084
+27,989
+0.5% +$1.14M 0.03% 588
2015
Q4
$367M Buy
5,646,095
+29,542
+0.5% +$1.92M 0.05% 412
2015
Q3
$396M Buy
5,616,553
+21,828
+0.4% +$1.54M 0.06% 370
2015
Q2
$622M Buy
5,594,725
+11,957
+0.2% +$1.33M 0.08% 278
2015
Q1
$526M Buy
5,582,768
+88,420
+2% +$8.34M 0.07% 330
2014
Q4
$616M Buy
5,494,348
+243,889
+5% +$27.3M 0.08% 281
2014
Q3
$322M Buy
5,250,459
+158,813
+3% +$9.74M 0.04% 448
2014
Q2
$233M Buy
5,091,646
+1,450,967
+40% +$66.5M 0.03% 608
2014
Q1
$143M Buy
3,640,679
+1,409,114
+63% +$55.2M 0.02% 794
2013
Q4
$53.4M Hold
2,231,565
0.01% 1284
2013
Q3
$62.4M Buy
+2,231,565
New +$62.4M 0.01% 1178